BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 8614851)

  • 21. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients.
    Bastiaannet E; Liefers GJ; de Craen AJ; Kuppen PJ; van de Water W; Portielje JE; van der Geest LG; Janssen-Heijnen ML; Dekkers OM; van de Velde CJ; Westendorp RG
    Breast Cancer Res Treat; 2010 Dec; 124(3):801-7. PubMed ID: 20428937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New criteria for selecting elderly patients for breast cancer adjuvant treatment studies.
    Dellapasqua S; Colleoni M; Castiglione M; Goldhirsch A
    Oncologist; 2007 Aug; 12(8):952-9. PubMed ID: 17766654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
    Goss PE
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
    Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
    J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective.
    Husain LS; Collins K; Reed M; Wyld L
    Psychooncology; 2008 Apr; 17(4):410-6. PubMed ID: 17847124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Breast carcinoma in elderly patients; clinical aspects and treatment].
    Beex LV; Wobbes T
    Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):59-63. PubMed ID: 2424156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast malignancy.
    Bender HG; Schnürch HG
    Curr Opin Obstet Gynecol; 1991 Feb; 3(1):58-65. PubMed ID: 1878498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.
    Hughes KS; Schnaper LA; Berry D; Cirrincione C; McCormick B; Shank B; Wheeler J; Champion LA; Smith TJ; Smith BL; Shapiro C; Muss HB; Winer E; Hudis C; Wood W; Sugarbaker D; Henderson IC; Norton L; ; ;
    N Engl J Med; 2004 Sep; 351(10):971-7. PubMed ID: 15342805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biology of breast cancer in older women.
    Clark GM
    J Gerontol; 1992 Nov; 47 Spec No():19-23. PubMed ID: 1430878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant therapy in early breast cancer.
    Chittoor SR; Swain SM
    Am Fam Physician; 1991 Aug; 44(2):453-62. PubMed ID: 1858602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary breast cancer in the elderly.
    Lickley HL
    Can J Surg; 1997 Oct; 40(5):341-51. PubMed ID: 9336523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer in the elderly.
    Petrakis IE; Paraskakis S
    Arch Gerontol Geriatr; 2010; 50(2):179-84. PubMed ID: 19409626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfalls.
    Barni S; Cabiddu M; Petrelli F
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):185-98. PubMed ID: 20131995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW
    Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity.
    Vetter M; Huang DJ; Bosshard G; Güth U
    Acta Oncol; 2013 Jan; 52(1):57-65. PubMed ID: 23083423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coming of age: breast cancer in seniors.
    Muss HB
    Oncologist; 2010; 15 Suppl 5():57-65. PubMed ID: 21138956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of tamoxifen in the long-term treatment and prevention of breast cancer.
    Jordan VC
    Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.